Sulfamonomethoxine

CAS No. 1220-83-3

Sulfamonomethoxine( Sulfamonmethoxine )

Catalog No. M10835 CAS No. 1220-83-3

Sulfamonomethoxine is a long acting sulfonamide antibacterial agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 40 In Stock
5MG 29 In Stock
10MG 43 In Stock
25MG 51 In Stock
50MG 61 In Stock
100MG 76 In Stock
200MG 111 In Stock
500MG 182 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sulfamonomethoxine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfamonomethoxine is a long acting sulfonamide antibacterial agent.
  • Description
    Sulfamonomethoxine is a long acting sulfonamide antibacterial agent, used in blood kinetic studies,and blocks the synthesis of folic acid by inhibiting synthetase of dihydropteroate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Sulfamonmethoxine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    1220-83-3
  • Formula Weight
    280.31
  • Molecular Formula
    C11H12N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 42mg/mL
  • SMILES
    O=S(C1=CC=C(N)C=C1)(NC2=NC=NC(OC)=C2)=O
  • Chemical Name
    4-Amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ma J, et al. Environ Sci Pollut Res Int. 2014 Jun;21(12):7436-48.
molnova catalog
related products
  • Lathyrol

    Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance.

  • Aloveroside A

    Aloveroside A is a triglucosylnaphthalene derivative isolated from ethanolic extract of aloe vera. Aloveroside A has weak bACE inhibitory activity (inhibition rate at a dose of 100 μg/mL is approximately 18.68%).

  • [Lys3]–Bombesin

    [Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)